INMAS

New Delhi: Indian Institute of Chemical Technology (IICT), Hyderabad, a constituent laboratory of Council of Scientific and Industrial Research (CSIR), New Delhi, and Nosch Labs entered into a non-exclusive agreement for the transfer of the process knowhow for the synthesis of anti-Covid-19 drug 2-DG (2-Deoxy -D -Glucose). 2-DG has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), New Delhi, a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Hyderabad-based pharma company Dr Reddy’s Laboratories (DRL). Nosch Labs will commence manufacturing 2-DG drug after obtaining regulatory clearances from the Drugs Controller General of India…